Semaglutide for alcohol use and weight loss
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This study tests whether semaglutide, a medication that helps with weight loss, can also reduce alcohol cravings and drinking in people with alcohol use disorder. It may help you drink less and lose weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- Your body mass index (BMI) is between 30 and 49.9.
- You drink alcohol at least 3 times a week.
- You have moderate to severe alcohol use disorder.
- You are generally healthy and can attend study visits.
- If you are a woman, you are not pregnant or breastfeeding and use reliable birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
This trial tests if a once-weekly diabetes medication (semaglutide) can help people with alcohol use disorder who have had gastric bypass or sleeve gastrectomy in the past 7 years. It may reduce alcohol cravings or drinking.
This study tests if semaglutide (a GLP-1 RA medicine) can reduce alcohol consumption and improve liver fat and metabolism in people with obesity and fatty liver disease who drink above certain levels.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests whether a medication (semaglutide) can help veterans reduce or stop drinking alcohol. It is for veterans who drink heavily and have alcohol use disorder, and who are interested in cutting down.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
Hear when a new Alcohol Use Disorder (AUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.